Beteiligte

(Current Chairman) http://www.medchem.uni-tuebingen.de

• Chair Pharmaceutical/Medicinal Chemistry, Tübingen University
• 30 years in small molecule drug discovery & development (10a industry)
• 400 publications, 40 patent families, 3 candidates from bench to bedside (first into man)
• Strong interdisciplinary background (pharmacogenomics, academic drug discovery)

• Biotechnologist (Dr.-Ing.), Consultant for TüCAD₂, Chemical Research Director TEVA
• 20+ years in pharmaceutical industry (drug discovery, non-clinical and clinical DMPK, pharm./tox., API development
• Co-Founder and CEO of two spin-offs, both VC and publicly funded

Lehrstuhl für Mikrobielle Wirkstoffe

• Chair for Microbial Bioactive Compounds at Tübingen University
• Record in natural product antibiotics in both industry and academia
• Novel lead structures from natural sources for antibacterial drug discovery
• Discovery of novel targets for antibiotic action
• Co-Inventor of a resistance-breaking hospital antibiotic (currently Phase I clinical trials)

Research Group

• Pharmaceutical Chemist; background in Molecular Modelling, in silico screening, docking
• 3D-QSAR; Track record in industry co-operations and spin-offs
• Department of Pharmaceutical Chemistry, University of Kuopio

Innere Medizin VIII - Klinische Tumorbiologie

• Medical Director Department Internal Medicine VIII
• Clinical focus: Medicinal oncology and Hepatology
• Scientific focus: molecular biology, translational medicine, animal models of liver disease and liver cancer
• Awardee of the Gottfried Wilhelm Leibniz-Preis and recipient of an ERC Consolidator grant.